Last reviewed · How we verify

NCT04004130

Ultrasound Imaging of Subarachnoidal Space in Newborn Infants

Status unknown NA Last updated 1 July 2019
What this trial tests

NA trial testing Ultrasound imaging in Ultrasound in 2,000 participants. Status unknown.

Timeline
1 May 2019
Primary endpoint
30 September 2020
1 January 2021

Quick facts

Lead sponsorSzeged University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment2,000
Start date1 May 2019
Primary completion30 September 2020
Estimated completion1 January 2021
Sites1 location across Hungary

Drugs / interventions tested

Conditions studied

Sponsor

Szeged University

Who can join

Adults 1 Day to 7 Days, any sex, with Ultrasound or Newborn Infant. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Based on the ultrasound measurement of CSF/spinal cord ratio in neonates the investigators plan to define a normal range of CSF volume for 0-7 day old newborns. The investigators hypothise to be able to create an ultrasound measurement index/number to predict unsuccessful neonatalal LPs.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Ultrasound imaging

Trials testing the same drug.

Other recruiting trials for Ultrasound

Currently open trials in the same condition.

Other Szeged University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04004130.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing